PMID- 21510771 OWN - NLM STAT- MEDLINE DCOM- 20111108 LR - 20220330 IS - 1557-7740 (Electronic) IS - 1557-7740 (Linking) VI - 14 IP - 6 DP - 2011 Jun TI - Symptoms, comorbidities, and health care in advanced chronic obstructive pulmonary disease or chronic heart failure. PG - 735-43 LID - 10.1089/jpm.2010.0479 [doi] AB - BACKGROUND: Patients with advanced chronic obstructive pulmonary disease (COPD) or chronic heart failure (CHF) may experience significant symptom distress. For development of palliative care programs that adequately address symptoms of patients with COPD or CHF, it is necessary to know severity of symptom distress and to gain insight in comorbidities and current provision of health care. Objective of the present cross-sectional observational study was to assess severity of symptoms, presence of comorbidities, and current provision of health care in outpatients with advanced COPD or CHF. METHODS: A total of 105 outpatients with clinically stable but advanced COPD (Global initiative for chronic Obstructive Lung Disease [GOLD] stage III or IV) and 80 patients with advanced CHF (New York Heart Association [NYHA] class III or IV) were assessed for demographics, clinical characteristics, self-reported comorbidities, and severity of symptoms using visual analogue scales. In addition, current health care and symptom-related interventions have been assessed. RESULTS: Comorbidities were reported by 96.3% of the CHF patients and 61.9% of the COPD patients. Patients suffered from multiple symptoms, like dyspnea, fatigue, muscle weakness, coughing, low mood, sleeplessness, and frequent micturition. For most symptoms, only the minority of patients had received symptom-related treatment. Involvement of allied health care professionals was low. The majority of COPD and CHF patients had received home adaptation and medical aids. CONCLUSIONS: Patients with advanced COPD or CHF experience comorbidities and suffer from multiple symptoms, which are often under treated. Further development and implementation of palliative care programs, consisting of regular assessment of the patients' comorbidities and symptoms as well as the provision of patient-tailored interventions is needed. FAU - Janssen, Daisy J A AU - Janssen DJ AD - Program Development Centre, CIRO+, Centre of Expertise for Chronic Organ Failure, Horn, The Netherlands. daisyjanssen@proteion.nl FAU - Spruit, Martijn A AU - Spruit MA FAU - Uszko-Lencer, Nicole H AU - Uszko-Lencer NH FAU - Schols, Jos M G A AU - Schols JM FAU - Wouters, Emiel F M AU - Wouters EF LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20110421 PL - United States TA - J Palliat Med JT - Journal of palliative medicine JID - 9808462 SB - IM MH - Aged MH - *Comorbidity MH - Cross-Sectional Studies MH - Female MH - Heart Failure/epidemiology/*physiopathology MH - Humans MH - Male MH - Middle Aged MH - Netherlands/epidemiology MH - Pulmonary Disease, Chronic Obstructive/epidemiology/*physiopathology EDAT- 2011/04/23 06:00 MHDA- 2011/11/09 06:00 CRDT- 2011/04/23 06:00 PHST- 2011/04/23 06:00 [entrez] PHST- 2011/04/23 06:00 [pubmed] PHST- 2011/11/09 06:00 [medline] AID - 10.1089/jpm.2010.0479 [doi] PST - ppublish SO - J Palliat Med. 2011 Jun;14(6):735-43. doi: 10.1089/jpm.2010.0479. Epub 2011 Apr 21.